Nov 27 (Reuters) - Datametrex AI Ltd DM.V :
* NEXALOGY ENTERS INTO LICENSE AND DEVELOPMENT AGREEMENT WITH REVIVE TO DEVELOP AI COMPONENT IN BLOCKCHAIN ENABLED PATIENT-FOCUSED PROGRAM
* DATAMETREX AI LTD- UNIT HAS ENTERED INTO A LICENSE AND DEVELOPMENT AGREEMENT WITH REVIVE THERAPEUTICS
* DATAMETREX AI LTD- UNDER TERMS OF AGREEMENT, CO WILL RECEIVE AN UPFRONT LICENSE FEE ALONG WITH MONTHLY FEES